|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stanley ER, Berg KL, Einstein DB, Lee PS,
Pixley FJ, Wang Y and Yeung YG: Biology and action of
colony-stimulating factor-1. Mol Reprod Dev. 46:4–10. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stanley ER, Berg KL, Einstein DB, Lee PS
and Yeung YG: The biology and action of colony stimulating
factor-1. Stem Cells. 12(Suppl 1): 15–24. 1994.PubMed/NCBI
|
|
4
|
Sapi E: The role of CSF-1 in normal
physiology of mammary gland and breast cancer: An update. Exp Biol
Med (Maywood). 229:1–11. 2004.
|
|
5
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hughes R, Qian BZ, Rowan C, Muthana M,
Keklikoglou I, Olson OC, Tazzyman S, Danson S, Addison C, Clemons
M, et al: Perivascular M2 macrophages stimulate tumor relapse after
chemotherapy. Cancer Res. 75:3479–3491. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sugimura K, Miyata H, Tanaka K, Takahashi
T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori M and Doki
Y: High infiltration of tumor-associated macrophages is associated
with a poor response to chemotherapy and poor prognosis of patients
undergoing neoadjuvant chemotherapy for esophageal cancer. J Surg
Oncol. 111:752–759. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sasayama T, Tanaka K, Mizowaki T,
Nagashima H, Nakamizo S, Tanaka H, Nishihara M, Mizukawa K, Hirose
T, Itoh T, et al: Tumor-associated macrophages associate with
cerebrospinal fluid interleukin-10 and survival in primary central
nervous system lymphoma (PCNSL). Brain Pathol. 26:479–487. 2016.
View Article : Google Scholar
|
|
9
|
Gordon S: Alternative activation of
macrophages. Nat Rev Immunol. 3:23–35. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Svensson J, Jenmalm MC, Matussek A,
Geffers R, Berg G and Ernerudh J: Macrophages at the fetal-maternal
interface express markers of alternative activation and are induced
by M-CSF and IL-10. J Immunol. 187:3671–3682. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wynn TA, Chawla A and Pollard JW:
Macrophage biology in development, homeostasis and disease. Nature.
496:445–455. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Geissmann F, Manz MG, Jung S, Sieweke MH,
Merad M and Ley K: Development of monocytes, macrophages, and
dendritic cells. Science. 327:656–661. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park KY, Li G and Platt MO:
Monocyte-derived macrophage assisted breast cancer cell invasion as
a personalized, predictive metric to score metastatic risk. Sci
Rep. 5:138552015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu KD, Li JJ, Di GH, Wu J, Shen ZZ and
Shao ZM: A straight-forward but not piecewise relationship between
age and lymph node status in Chinese breast cancer patients. PLoS
One. 5:e110352010. View Article : Google Scholar
|
|
15
|
Hannan NJ, Bambang K, Kaitu'u-Lino TJ,
Konje JC and Tong S: A bioplex analysis of cytokines and chemokines
in first trimester maternal plasma to screen for predictors of
miscarriage. PLoS One. 9:e933202014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee KS, Chung JH, Lee KH, Shin MJ, Oh BH
and Hong CH: Bioplex analysis of plasma cytokines in Alzheimer's
disease and mild cognitive impairment. Immunol Lett. 121:105–109.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim YW, Kim SK, Kim CS, Kim IY, Cho MY and
Kim NK: Association of serum and intratumoral cytokine profiles
with tumor stage and neutrophil lymphocyte ratio in colorectal
cancer. Anticancer Res. 34:3481–3487. 2014.PubMed/NCBI
|
|
18
|
Shigeoka M, Urakawa N, Nakamura T, Nishio
M, Watajima T, Kuroda D, Komori T, Kakeji Y, Semba S and Yokozaki
H: Tumor associated macrophage expressing CD204 is associated with
tumor aggressiveness of esophageal squamous cell carcinoma. Cancer
Sci. 104:1112–1119. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kaku Y, Imaoka H, Morimatsu Y, Komohara Y,
Ohnishi K, Oda H, Takenaka S, Matsuoka M, Kawayama T, Takeya M, et
al: Overexpression of CD163, CD204 and CD206 on alveolar
macrophages in the lungs of patients with severe chronic
obstructive pulmonary disease. PLoS One. 9:e874002014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Györffy B, Lanczky A, Eklund AC, Denkert
C, Budczies J, Li Q and Szallasi Z: An online survival analysis
tool to rapidly assess the effect of 22,277 genes on breast cancer
prognosis using microarray data of 1,809 patients. Breast Cancer
Res Treat. 123:725–731. 2010. View Article : Google Scholar
|
|
21
|
Hass R, Bartels H, Topley N, Hadam M,
Köhler L, Goppelt-Strübe M and Resch K: TPA-induced differentiation
and adhesion of U937 cells: Changes in ultrastructure, cytoskeletal
organization and expression of cell surface antigens. Eur J Cell
Biol. 48:282–293. 1989.PubMed/NCBI
|
|
22
|
Fulton RJ, McDade RL, Smith PL, Kienker LJ
and Kettman JR Jr: Advanced multiplexed analysis with the
FlowMetrix system. Clin Chem. 43:1749–1756. 1997.PubMed/NCBI
|
|
23
|
Schmieder A, Michel J, Schönhaar K, Goerdt
S and Schledzewski K: Differentiation and gene expression profile
of tumor-associated macrophages. Semin Cancer Biol. 22:289–297.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Obeid E, Nanda R, Fu YX and Olopade OI:
The role of tumor-associated macrophages in breast cancer
progression (Review). Int J Oncol. 43:5–12. 2013.PubMed/NCBI
|
|
25
|
Kennedy BC, Showers CR, Anderson DE,
Anderson L, Canoll P, Bruce JN and Anderson RC: Tumor-associated
macrophages in glioma: Friend or foe? J Oncol. 2013:4869122013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Marino N, Woditschka S, Reed LT, Nakayama
J, Mayer M, Wetzel M and Steeg PS: Breast cancer metastasis: Issues
for the personalization of its prevention and treatment. Am J
Pathol. 183:1084–1095. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hanahan D and Coussens LM: Accessories to
the crime: Functions of cells recruited to the tumor
microenvironment. Cancer Cell. 21:309–322. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kelly PM, Davison RS, Bliss E and McGee
JO: Macrophages in human breast disease: A quantitative
immunohistochemical study. Br J Cancer. 57:174–177. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Medrek C, Pontén F, Jirström K and
Leandersson K: The presence of tumor associated macrophages in
tumor stroma as a prognostic marker for breast cancer patients. BMC
Cancer. 12:3062012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tsutsui S, Yasuda K, Suzuki K, Tahara K,
Higashi H and Era S: Macrophage infiltration and its prognostic
implications in breast cancer: The relationship with VEGF
expression and microvessel density. Oncol Rep. 14:425–431.
2005.PubMed/NCBI
|
|
32
|
Chaturvedi P, Gilkes DM, Takano N and
Semenza GL: Hypoxia-inducible factor-dependent signaling between
triple-negative breast cancer cells and mesenchymal stem cells
promotes macrophage recruitment. Proc Natl Acad Sci USA.
111:E2120–E2129. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin EY, Nguyen AV, Russell RG and Pollard
JW: Colony-stimulating factor 1 promotes progression of mammary
tumors to malignancy. J Exp Med. 193:727–740. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wyckoff J, Wang W, Lin EY, Wang Y, Pixley
F, Stanley ER, Graf T, Pollard JW, Segall J and Condeelis J: A
paracrine loop between tumor cells and macrophages is required for
tumor cell migration in mammary tumors. Cancer Res. 64:7022–7029.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pollard JW: Tumour-educated macrophages
promote tumour progression and metastasis. Nat Rev Cancer. 4:71–78.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Qian BZ, Li J, Zhang H, Kitamura T, Zhang
J, Campion LR, Kaiser EA, Snyder LA and Pollard JW: CCL2 recruits
inflammatory monocytes to facilitate breast-tumour metastasis.
Nature. 475:222–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Paik S, Shak S, Tang G, Kim C, Baker J,
Cronin M, Baehner FL, Walker MG, Watson D, Park T, et al: A
multigene assay to predict recurrence of tamoxifen-treated,
node-negative breast cancer. N Engl J Med. 351:2817–2826. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shabo I, Stål O, Olsson H, Doré S and
Svanvik J: Breast cancer expression of CD163, a macrophage
scavenger receptor, is related to early distant recurrence and
reduced patient survival. Int J Cancer. 123:780–786. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lin JA, Lin FY and Chen TL: Bone
components downregulate expression of toll-like receptor 4 on the
surface of human monocytic U937 cells: A cell model for
postfracture immune dysfunction. Mediators Inflamm.
2015:8965762015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Martin-Manso G, Galli S, Ridnour LA,
Tsokos M, Wink DA and Roberts DD: Thrombospondin 1 promotes tumor
macrophage recruitment and enhances tumor cell cytotoxicity of
differentiated U937 cells. Cancer Res. 68:7090–7099. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang XV, Banerjee Y, Fernández JA, Deguchi
H, Xu X, Mosnier LO, Urbanus RT, de Groot PG, White-Adams TC,
McCarty OJ, et al: Activated protein C ligation of ApoER2 (LRP8)
causes Dab1-dependent signaling in U937 cells. Proc Natl Acad Sci
USA. 106:274–279. 2009. View Article : Google Scholar : PubMed/NCBI
|
